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The study aimed at immunocytochemical evaluation of the cellular expression of
two cytokines, IL-2 and IL-12 in lung carcinoids (n = 10), following the earlier
demonstration of two markers of endocrine tumours (chromogranin A and NSE
— neuron-specific enolase). In the immunocytochemical studies the classical
avidin-biotinylated peroxidase (ABC) technique was used. Results of the tests
were semiquantitatively appraised employing the IRS scale. In 9/10 cases intense
reaction (score: 6–12 points) was noted for both lung neuroendocrine markers.
In all cases of carcinoma co-expression of IL-2 and IL-12 was demonstrated in
cells of the tumours. The cytokines showed a cytoplasmic localisation of mean
(score: 3–4 points) or high (score: 6–12 points) intensity of reaction. Our studies
point to a possible role of the two cytokines in the proliferation of lung neu-
roendocrine carcinomas but more detailed analysis is required on a broader
material.
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INTRODUCTION
Lung neuroendocrine tumours include carcino-
ids, large-cell neuroendocrine carcinomas (LCNEC)
and small-cell lung carcinomas (SCLC) [5]. Out of
numerous markers of neuroendocrine tumours, chro-
mogranin A, synaptophysin, neuron-specific enolase
(NSE) and protein gene product 9.5 (PGP 9.5) [5, 6]
have been most frequently detected. The role of lym-
phoid cell-secreted interleukin 2 (IL-2) and interleu-
kin 12 (IL-12) in the activation of an anti-tumour
immune response in humans has generally been rec-
ognised but few data exist on secretion of the cy-
tokines by the tumour cells themselves [2, 7]. Tissue
expression of the two cytokines in neuroendocrine
lung tumours remains unknown. The present study
therefore aimed at immunocytochemical analysis of
the expression of the two cytokines, i.e. IL-2 and IL-12,
in selected neuroendocrine tumours of the lungs.
MATERIAL AND METHODS
The studies were performed on lung carcinoids
of patients (n = 10) treated in the Independent Pub-
lic Hospital for Lung Diseases in Zakopane. In each
case the diagnosis of typical (8) and atypical (2) lung
carcinoids was confirmed by histopathology. Tumour
samples obtained during surgery were fixed in 10%
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buffered formalin and embedded in paraffin blocks.
In immunocytochemical tests, performed using ABC
technique, the following monoclonal antibodies were
used: a) rabbit anti-human chromogranin A antibody,
(b) mouse anti-human NSE antibody (both from
DAKO), (c) mouse anti-human IL-2 antibody, (d) mouse
anti-human IL-12 antibody (the latter two from R&D
Systems). The control reactions employed control sera
of the respective species (negative control) (DAKO)
and reactive lymph nodes (n = 3) of healthy patients
(positive control). The intensity of the immunocy-
tochemical reactions for neuroendocrine markers and
both cytokines was evaluated employing the semi-
quantitative IRS scale according to Remmele and
Stegner [3], taking into account the intensity of the
colour reaction and the number of positive cells. The
final score represented a product of scores repre-
senting the two variables and ranged from 0 to 12
points (low reaction: 1 to 2 points, average reac-
tion: 3 to 4 points, intense reaction: 6 to 12 points).
RESULTS AND DISCUSSION
The presence of chromogranin A and of NSE was
demonstrated in all lung carcinoids, which con-
firmed the role of the markers in supplementing
a diagnosis of lung neuroendocrine tumours [5, 6].
Intense reaction (score: 6–12) for both markers pre-
vailed. In all the cases co-expression of IL-2 and IL-12
was also demonstrated. In two cases the intensity
of reaction for IL-2 was low, in two cases it was
moderate and in 6 cases it was high. Expression of
IL-12 was moderate in half the cases and high in
the other half. Cytoplasmic localisation of the cy-
tokines was demonstrated, frequently of a granu-
lar character (Fig. 1). Immunoreactivity in mononu-
clear cells (lymphocytes, macrophages) for the two
cytokines in the vicinity of the tumour was very sel-
dom observed. Pronounced production of endoge-
nous IL-2 by tumour cells in vitro and in vivo and its
correlation with expression of Ki-67 and with his-
tological tumour grade has already been demon-
strated in cases of head and neck squamous cell
carcinomas [4]. Our studies point to a possible role
of IL-2 and IL-12 in tumour cell proliferation in cas-
es of lung carcinoids also. However, the prelimi-
nary observations should be extended in studies on
a larger material of patients and on other types of
lung neuroendocrine tumours.
Figure 1. Immunocytochemical localisation of IL-12 in cancer cells of lung carcinoid; ABC method; ¥ 400.
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